Clinical Quality Oversight has ended
avatar for Lynne Cesario

Lynne Cesario

Senior Director, Global Risk-Based Monitoring Program Lead
Lynne Cesario has more than 24 years of experience in clinical research and drug development in the pharmaceutical industry. She is currently a Senior Director in the Data Monitoring and Management department, leading the Global Risk Based Monitoring Program at Pfizer. As the overall business lead point of contact for RBM, Lynne coordinates and aligns all cross functional project workstreams. Lynne also manages the global Central Monitoring teams, as well as a Data Science team that focuses on AI and automations that can be employed in the biometrics space. Lynne is an active member of Transcelerate where she co-led the RBM Workstream.
  • Timezone
  • Filter By Date Clinical Quality Oversight Sep 27 -29, 2021
  • Filter By Type
  • General Session - Live Streamed to Virtual Audience
  • Interactive Workshop - In-Person Only
  • Networking!
  • Track A - In-Person Only
  • Track B - In-Person Only